DENTSPLY SIRONA Inc (NASDAQ: XRAY) has reported earnings for its first fiscal quarter (ending March 31) of $0.09 versus a loss $-0.09 for the same period a year ago. This result fell short of the consensus estimate of $0.54 by $-0.44. E.P.S. were $-0.43 for the latest four quarters through March 31 versus $-4.83 for the same period a year ago.
Recent Price Action
On 5/2/24, DENTSPLY SIRONA Inc (NASDAQ: XRAY) stock suffered a large decline of -6.0%, closing at $28.38. Moreover, this decline was accompanied by unusually high trading volume at 185% of normal. Relative to the market the stock has been weak over the last nine months and has declined -8.2% during the last week.
Current PriceTarget Research Rating
XRAY’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be an important Value Builder.
DENTSPLY SIRONA has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. DENTSPLY SIRONA has a slightly negative Appreciation Score of 32 and a poor Power Rating of 18, and the Lowest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment